Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome–Negative B-Precursor ALL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL
J. Clin. Oncol 2023 Oct 26;[EPub Ahead of Print], M Stelljes, S Raffel, N Alakel, R Wäsch, M Kondakci, S Scholl, A Rank, M Hänel, B Spriewald, M Hanoun, S Martin, K Schwab, H Serve, L Reiser, J Knaden, H Pfeifer, J Marx, T Sauer, WE Berdel, G Lenz, M Brüggemann, N Gökbuget, K WethmarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.